10 Oct 2024
// PRESS RELEASE
10 Oct 2024
// PRESS RELEASE
10 Oct 2024
// PRESS RELEASE
Latest Content by PharmaCompass
Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.
About
Industry Trade Show
Attending
17-20 March, 2025
CPhI North America CPhI North America
Industry Trade Show
Attending
20-22 May, 2025
Industry Trade Show
Attending
09-11 June, 2025
CONTACT DETAILS
Events
Webinars & Exhibitions
Industry Trade Show
Attending
17-20 March, 2025
CPhI North America CPhI North America
Industry Trade Show
Attending
20-22 May, 2025
Industry Trade Show
Attending
09-11 June, 2025
https://www.pharmacompass.com/speak-pharma/polpharma-has-invested-over-35mln-euros-in-a-completely-new-facility-to-handle-hpapis
CORPORATE CONTENT #SupplierSpotlight
https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-bora-polpharma-make-acquisitions-evonik-euroapi-porton-announce-technological-expansions
https://www.pharmacompass.com/radio-compass-blog/fda-approves-record-eight-biosimilars-in-h1-2024-okays-first-interchangeable-biosimilars-for-eylea
10 Oct 2024
// PRESS RELEASE
https://www.api.polpharma.com/articles/polpharmas-hp-api-facility-is-live
10 Oct 2024
// PRESS RELEASE
https://www.api.polpharma.com/articles/rising-prevalence-of-cancer-and-its-impact-on-the-hp-api-market
10 Oct 2024
// PRESS RELEASE
https://www.api.polpharma.com/articles/addressing-nitrosamine-risks-in-pharmaceutical-manufacturing
01 Oct 2024
// PRESS RELEASE
23 Sep 2024
// PRESS RELEASE
https://polpharma.pl/en/polpharma-and-msn-laboratories-announce-strategic-distribution-partnership/
12 Sep 2024
// PRESS RELEASE
https://www.api.polpharma.com/news/polpharmas-strategic-investment-in-hpapi-facility-the-first-of-this-kind-in-poland/
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-01-30
Pay. Date : 2013-01-15
DMF Number : 10383
Submission : 1993-07-30
Status : Active
Type : II